Ocean acidification impacts

Ocean acidification impacts are becoming increasingly relevant to pharmaceutics, particularly in the realm of marine-based drug discovery and sustainable sourcing of raw materials. Ocean acidification, caused by the absorption of excess atmospheric CO2 into seawater, lowers pH levels and disrupts the delicate balance of marine ecosystems. Many marine organisms—such as shellfish, corals, algae, and sponges—are sensitive to pH changes, and these species often serve as sources of bioactive compounds used in pharmaceutical research. As ocean acidification threatens biodiversity and weakens marine food webs, it also jeopardizes access to novel compounds with antimicrobial, anticancer, or anti-inflammatory properties. This poses a risk to future drug discovery pipelines that depend on marine biodiversity.

Beyond drug discovery, ocean acidification impacts the broader environmental context in which pharmaceutics operates. Deteriorating ocean health can increase the presence of marine toxins and harmful algal blooms, which may interfere with the safe harvesting of marine-derived excipients or ingredients. In coastal areas where pharmaceutical facilities are located, acidified waters may also affect local water quality and infrastructure, leading to increased maintenance costs and stricter purification requirements. As the pharmaceutical industry moves toward more sustainable and environmentally integrated practices, understanding and addressing the effects of ocean acidification becomes essential—not just for ecological protection, but also for long-term pharmaceutical innovation and resource stability.